Increased Susceptibility of Humanized NSG Mice to Panton-Valentine Leukocidin and Staphylococcus aureus Skin Infection

PLoS Pathogens

Volumn 11, Issue 11, 2015, Pages

  Tseng, Ching Wen ^a,b   Biancotti, Juan Carlos ^c   Berg, Bethany L ^a,b   Gate, David ^a,c   Kolar, Stacey L ^a,b   Müller, Sabrina ^a,b   Rodriguez, Maria D ^a,b   Rezai Zadeh, Kavon ^a,e   Fan, Xuemo ^a   Beenhouwer, David O ^b,d   Town, Terrence ^c   Liu, George Y ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^e PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; COMPLEMENT COMPONENT C5A RECEPTOR; INTERLEUKIN 8; MYELOPEROXIDASE; PANTON VALENTINE LEUKOCIDIN; BACTERIAL TOXIN; EXOTOXIN; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL MODEL; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; FLOW CYTOMETRY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LYMPHOCYTE SUBPOPULATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; MTT ASSAY; NEUTROPHIL; NONHUMAN; PHENOTYPE; SKIN DEFECT; SKIN NECROSIS; SOFT TISSUE INFECTION; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; ANIMAL; DISEASE MODEL; DISEASE PREDISPOSITION; IMMUNOLOGY; MICROBIOLOGY; STAPHYLOCOCCAL SKIN INFECTIONS;

ANIMALS; BACTERIAL TOXINS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; EXOTOXINS; HUMANS; LEUKOCIDINS; MICE; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84948961540     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005292     Document Type: Article

References (35)

1. Talan DA, Krishnadasan A, Gorwitz RJ, Fosheim GE, Limbago B, et al. (2011) Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin Infect Dis 53: 144–149. doi: 10.1093/cid/cir308 21690621
2. DuMont AL, Torres VJ, (2014) Cell targeting by the Staphylococcus aureus pore-forming toxins: it's not just about lipids. Trends Microbiol 22: 21–27. doi: 10.1016/j.tim.2013.10.004 24231517
3. Spaan AN, Vrieling M, Wallet P, Badiou C, Reyes-Robles T, et al. (2014) The staphylococcal toxins gamma-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors. Nat Commun 5: 5438. doi: 10.1038/ncomms6438 25384670
4. Fowler VG, Jr.Proctor RA, (2014) Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect 20 Suppl 5: 66–75. doi: 10.1111/1469-0691.12570 24476315
5. Spaan AN, Surewaard BG, Nijland R, van Strijp JA, (2013) Neutrophils versus Staphylococcus aureus: a biological tug of war. Annu Rev Microbiol 67: 629–650. doi: 10.1146/annurev-micro-092412-155746 23834243
6. Bunce C, Wheeler L, Reed G, Musser J, Barg N, (1992) Murine model of cutaneous infection with gram-positive cocci. Infect Immun 60: 2636–2640. 1612733
7. Elek SD, (1956) Experimental staphylococcal infections in the skin of man. Ann N Y Acad Sci 65: 85–90. 13363202
8. Singh G, Marples RR, Kligman AM, (1971) Experimental Staphylococcus aureus infections in humans. J Invest Dermatol 57: 149–162. 4937674
9. Otto M, (2013) Community-associated MRSA: what makes them special? Int J Med Microbiol 303: 324–330. doi: 10.1016/j.ijmm.2013.02.007 23517691
10. Liu GY, (2009) Molecular pathogenesis of Staphylococcus aureus infection. Pediatr Res 65: 71R–77R. doi: 10.1203/PDR.0b013e31819dc44d 19190527
11. Bubeck Wardenburg J, Bae T, Otto M, Deleo FR, Schneewind O, (2007) Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 13: 1405–1406. 18064027
12. Tseng CW, Kyme P, Low J, Rocha MA, Alsabeh R, et al. (2009) Staphylococcus aureus Panton-Valentine leukocidin contributes to inflammation and muscle tissue injury. PLoS One 4: e6387. doi: 10.1371/journal.pone.0006387 19633710
13. Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, et al. (2006) Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 194: 1761–1770. 17109350
14. Labandeira-Rey M, Couzon F, Boisset S, Brown EL, Bes M, et al. (2007) Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315: 1130–1133. 17234914
15. Spaan AN, Henry T, van Rooijen WJ, Perret M, Badiou C, et al. (2013) The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors. Cell Host Microbe 13: 584–594. doi: 10.1016/j.chom.2013.04.006 23684309
16. Leung C, Chijioke O, Gujer C, Chatterjee B, Antsiferova O, et al. (2013) Infectious diseases in humanized mice. Eur J Immunol 43: 2246–2254. doi: 10.1002/eji.201343815 23913412
17. Libby SJ, Brehm MA, Greiner DL, Shultz LD, McClelland M, et al. (2010) Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection. Proc Natl Acad Sci U S A 107: 15589–15594. doi: 10.1073/pnas.1005566107 20713716
18. Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL, (2012) Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol 12: 786–798. doi: 10.1038/nri3311 23059428
19. Heuts F, Gavier-Widen D, Carow B, Juarez J, Wigzell H, et al. (2013) CD4+ cell-dependent granuloma formation in humanized mice infected with mycobacteria. Proc Natl Acad Sci U S A 110: 6482–6487. doi: 10.1073/pnas.1219985110 23559373
20. Knop J, Hanses F, Leist T, Archin NM, Buchholz S, et al. (2015) Staphylococcus aureus Infection in Humanized Mice: A New Model to Study Pathogenicity Associated With Human Immune Response. J Infect Dis.
21. Brehm MA, Racki WJ, Leif J, Burzenski L, Hosur V, et al. (2012) Engraftment of human HSCs in nonirradiated newborn NOD-scid IL2rgamma null mice is enhanced by transgenic expression of membrane-bound human SCF. Blood 119: 2778–2788. doi: 10.1182/blood-2011-05-353243 22246028
22. Szmigielski S, Prevost G, Monteil H, Colin DA, Jeljaszewicz J, (1999) Leukocidal toxins of staphylococci. Zentralbl Bakteriol 289: 185–201. 10360319
23. Bugl S, Wirths S, Radsak MP, Schild H, Stein P, et al. (2012) Steady-state neutrophil homeostasis is dependent on TLR4/TRIF signaling. Blood 121: 723–733. doi: 10.1182/blood-2012-05-429589 23223360
24. Bradley PP, Priebat DA, Christensen RD, Rothstein G, (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206–209. 6276474
25. Bao L, Osawe I, Puri T, Lambris JD, Haas M, et al. (2005) C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur J Immunol 35: 2496–2506. 16052609
26. Proctor LM, Arumugam TV, Shiels I, Reid RC, Fairlie DP, et al. (2004) Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury. Br J Pharmacol 142: 756–764. 15159277
27. Woodruff TM, Strachan AJ, Sanderson SD, Monk PN, Wong AK, et al. (2001) Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes. Inflammation 25: 171–177. 11403208
28. Spaan AN, Schiepers A, de Haas CJ, van Hooijdonk DD, Badiou C, et al. (2015) Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and gamma-Hemolysin CB with Human C5a Receptors. J Immunol 195: 1034–1043. doi: 10.4049/jimmunol.1500604 26091719
29. Pishchany G, McCoy AL, Torres VJ, Krause JC, Crowe JE, Jr.et al. (2010) Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe 8: 544–550. doi: 10.1016/j.chom.2010.11.002 21147468
30. de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, et al. (2004) Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 199: 687–695. 14993252
31. Malachowa N, Whitney AR, Kobayashi SD, Sturdevant DE, Kennedy AD, et al. (2011) Global changes in Staphylococcus aureus gene expression in human blood. PLoS One 6: e18617. doi: 10.1371/journal.pone.0018617 21525981
32. Tanaka S, Saito Y, Kunisawa J, Kurashima Y, Wake T, et al. (2012) Development of mature and functional human myeloid subsets in hematopoietic stem cell-engrafted NOD/SCID/IL2rgammaKO mice. J Immunol 188: 6145–6155. doi: 10.4049/jimmunol.1103660 22611244
33. Johnston SC, Dustin ML, Hibbs ML, Springer TA, (1990) On the species specificity of the interaction of LFA-1 with intercellular adhesion molecules. J Immunol 145: 1181–1187. 2199576
34. Biancotti JC, Town T, (2013) Increasing hematopoietic stem cell yield to develop mice with human immune systems. Biomed Res Int 2013: 740892. doi: 10.1155/2013/740892 23509770
35. Andrews PC, Krinsky NI, (1982) Quantitative determination of myeloperoxidase using tetramethylbenzidine as substrate. Anal Biochem 127: 346–350. 6299132